1 |
Fousekis FS, Theopistos VI, Katsanos KH, et al. Hepatobiliary manifestations and complications in inflammatory bowel disease: a review [J]. Gastroenterology Res, 2018, 11(2): 83-94.
|
2 |
Iqbal U, Siddiqui HU, Anwar H, et al. Allopurinol-induced granulomatous hepatitis: a case report and review of literature [J]. J Investig Med High Impact Case Rep, 2017, 5(3): 1561909534.
|
3 |
Braun M, Fraser GM, Kunin M, et al. Mesalamine-induced granulomatous hepatitis [J]. Am J Gastroenterol, 1999, 94(7): 1973-1974.
|
4 |
Barrera L, Alvarez J, Tapias M, et al. Granulomatous hepatitis secondary to histoplasma infection after treatment with infliximab [J]. Case Reports Hepatol, 2013, 2013: 807537.
|
5 |
Flamm SL. Granulomatous liver disease [J]. Clin Liver Dis, 2012, 16(2): 387-396.
|
6 |
Restellini S, Chazouillères O, Frossard J. Hepatic manifestations of inflammatory bowel diseases [J]. Liver Int, 2017, 37(4): 475-489.
|
7 |
Jo PC, Jang HJ, Burns PN, et al. Integration of contrast-enhanced US into a multimodality approach to imaging of nodules in a cirrhotic liver: how i do it [J]. Radiology, 2017, 282(2): 317-331.
|
8 |
Liu GJ, Lu MD, Xie XY, et al. Real-time contrast-enhanced ultrasound imaging of infected focal liver lesions [J]. J Ultrasound Med, 2008, 27(4): 657-666.
|
9 |
Kunze G, Staritz M, Kohler M. Contrast-enhanced ultrasound in different stages of pyogenic liver abscess [J]. Ultrasound Med Biol, 2015, 41(4): 952-959.
|